Clinical Trial Update: Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial assessed safety and potential efficacy of adding alanyl-glutamine-dipeptide to peritoneal dialysis solution in end-stage renal disease; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Alanyl-Glutamine-Dipeptide (alanyl-glutamine-dipeptide)

Snippet

Sponsor: Christoph Aufricht | Conditions: End Stage Renal Disease | Phase 1, Phase 2 | Status: TERMINATED